相关实验视频
Updated: Jul 12, 2025

08:15
Gastrointestinal Motility Monitor GIMM
Published on: December 1, 2010
30.9K
皮科145抑制TRPC4介导的MICAT和食后小肠运动
Dariia O Dryn1, Mariia I Melnyk2, Robin S Bon3
1A.A. Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, 4 Bogomoletz Str., Kyiv 01024, Ukraine.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|October 19, 2023
概括
TRPC4 抑制剂 Pico145 强烈地阻断了小鼠叶肌细胞中的肌糖体受体离子电流 (mICAT). 这种化合物有效地降低了肠道运动和延迟过渡,证明了其作为GI活性治疗药物的潜力.
科学领域:
- 身体生理学 身体生理学
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- TRPC4通道是肠滑肌中的肌肉受体离子电流 (mICAT) 的关键介质,驱动胆能刺激-收缩合.
- 了解TRPC4的作用和开发向抑制剂对于调节胃肠机动性至关重要.
研究的目的:
- 在小鼠模型中研究新型TRPC4抑制剂Pico145对mICAT,细胞内 (Ca2+) 信号和肠道运动的影响.
主要方法:
- 补丁电生理学和Fura-2成像被用来评估分离的乳腺肌细胞中的MICAT和Ca2+动态.
- 在体外张力测量,体外视频录制和体内红红色过境测量评估了对肠道运动的功能影响.
主要成果:
- 皮科145证明了卡巴霍尔诱导的mICAT的强烈抑制,其IC50为3.1 pM,并抑制了Ca2+升高,其IC50为2.7 pM.
- 抑制剂抑制了自发和引起的肠滑肌收缩,并显著延迟了食后肠道过渡.
- 在体内,Pico145的疗效与TRPC4基因缺陷相当.
结论:
- 皮科145是一种TRPC4通道的强效小分子抑制剂,在皮科分子度下有效抑制mICAT.
- 该化合物表现出显著的胃肠道活性,减少肌肉收缩和延迟过渡,突出其治疗动力障碍的治疗潜力.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
272
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
272
Gastric Motility
772
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
772
Enteric Nervous System: Regulation of GI Motor Activity
406
The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
406
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
350
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
350
Gastrointestinal Motility Disorders
394
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
394

